Should we apply?
7 questions about Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed. The first ones are deal-breakers: grant professionals check them before writing anything. We filled in what we know. Change anything that's wrong.